Navigation Links
BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
Date:10/22/2007

SAN ANTONIO, Oct. 22 /PRNewswire/ -- BioMedical Enterprises, Inc. (BME), a privately held medical device company and leader in orthopedic shape memory implant technology, today announced that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the OSSpine(TM) for use in anterior fixation of the cervical spine to provide enhanced biomechanical stability & bone graft retention. The patent-pending OSSpine(TM) builds on the extremity bone fusion success of BME's OSStaple(TM) and OSSplate(TM), and joins the Step OSStaple(TM) and the OSSArc(TM) dynamic residual compression implants as the most recent additions to BME's OSSforce(TM) Fixation System.

Made of nitinol, a biocompatible alloy possessing shape memory and super-elastic properties, the OSSpine(TM) implant is inserted while in its malleable state at room temperature. Using BME's patent-pending OSSforce(TM) Implant Controller, the implant is safely heated to activate its shape change and impart compression forces across the fusion site. During this process, the implant's legs close and it's s-shaped back shrinks providing uniform compression while the alloy's structure transforms into a state approximately 20% stronger then 316L stainless steel. The OSSpine(TM) implant actively compresses the fusion construct compensating for any graft subsidence that may occur during healing.

BME recently announced that it had received a Notice of Allowance from the United States Patent and Trademark Office for 61 claims providing protection for their innovative OSSforce(TM) Implant Controller technology. The OSSpine(TM) implants and the OSSforce(TM) Implant Controller will be showcased by BME at the North American Spine Society (NASS) 22nd Annual Meeting being held October 23-27, 2007 in Austin, Texas.

BioMedical Enterprises, Inc. (BME) is a medical device company that addresses the changing needs in musculoskeletal medicine. BME focuses on minimally invasive orthopaedic ins
'/>"/>

SOURCE BioMedical Enterprises, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Biomedical engineering conference invites manufacturers
2. Manufacturing partnership will move into biotech and biomedical spaces
3. Biomedical Alliance about more than stem cells
4. Doyle seeks $2.5M for biomedical alliance
5. Students will show off biomedical devices to professors and investors
6. Biomedical alliance marks first full year
7. UW Biomedical Engineering awarded $2.9 million research grant
8. Having two biomedical tech centers in Wisconsin will help the state
9. New biomedical institute aims to unite business and academia in SE Wisconsin
10. Wisconsin publicly traded biomedical companies report gains this quarter
11. Medical College receives $377K to study brain disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , REYKJAVIK, Iceland, Novemb...nc. (Nasdaq: DCGN ) today announced the approval o...uptcy Court for the District of Delaware,(the "Ban...y petition for,relief under Chapter 11 of the Unit...t. , The orders issued by the Bankruptcy ...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia...Food & Drug Administration (SFDA) has approved...r its oral insulin project,(Nodlin), an innovative...pproval allows Biolaxy to initiate its first phase...er characteristic of high blood glucose and poor,m...
(Date:11/24/2009)... , , Primary efficacy endpoint has been me...t endometrial cancer, , QUEBEC CITY, Nov. 24 ...SDAQ: AEZS ; TSX: AEZ) (the "Company"), a global ...rapy and oncology, today announced positive effica...otoxic peptide conjugate, AEZS-108 (formerly AN-15...
(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-Fi...ARNA ) announced today that the company is sched...ealth Care Conference on December 1, 2009 at 11:30... New York Palace Hotel in New York City. Jack Lief...s scheduled to provide an overview of the company,...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
... , Ambion has developed a complete line...croRNAs (miRNAs). Recently, we introduced the mir...ng of the mir Vana miRNA Labeling Kit , an... tools for interrogating , miRNA function a...recursor , Molecules, Anti-miR miRNA Inhibi...
... Remove >90% of mammalian RNA from , ... Simple procedure takes less than 2 hou...cies , Seamless integration with ...rification Kit , Enables micro...erial RNA isolated from host cells , ...
..., Sonal Patel, and David Quilter , ... , Efficient and cost-effe... aRNA in a high throughput format , ... Rapid, reliable, and consisten...science researchers need an , efficient and...
Other Biology Technology:Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 2Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 3Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 4Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 5Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 6Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 7Cancer-Related miRNAs Uncovered by the mirVana miRNA Microarray Platform 8Bacterial RNA Isolation From Infected Eukaryotic Hosts 2Bacterial RNA Isolation From Infected Eukaryotic Hosts 3Bacterial RNA Isolation From Infected Eukaryotic Hosts 4Bacterial RNA Isolation From Infected Eukaryotic Hosts 5Bacterial RNA Isolation From Infected Eukaryotic Hosts 6Automated RNA Amplification for Arrays 2Automated RNA Amplification for Arrays 3Automated RNA Amplification for Arrays 4Automated RNA Amplification for Arrays 5
(Date:11/24/2009)...pus Research Institute (LRI) today named 12 new gr... million, recognize innovative work across a broad... their creativity, novelty, and potential to drive..., and cure the complex disease of systemic lupus. ... lupus researchers across the nation and include i...
(Date:11/24/2009)...omic-level action of a remarkable class of ring-sh...ers with the Lawrence Berkeley National Laboratory...rystallography beamline at the Advanced Light Sour...in gene expression and replication, and are vital ...s infectious agents, such as the human papillomavi...
(Date:11/24/2009)...constitutes fish food is a matter of debate. A hig...h get almost 50 percent of their carbon from trees...n the terrestrial and aquatic ecosystems. , But ...ws this is not likely to be true. Algae provide a ...according to research published this week in the ...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Lymphoma Research Foundation announces recipients of CLL SLL Research Initiative grants 60249 1Lymphoma Research Foundation announces recipients of CLL SLL Research Initiative grants 60249 2Next generation microcapsules deliver chemicals on demand 10562 1UD start up company prepares to commercialize novel detector for medical military applications 10557 1UD start up company prepares to commercialize novel detector for medical military applications 10557 2UD start up company prepares to commercialize novel detector for medical military applications 10557 3UD start up company prepares to commercialize novel detector for medical military applications 10557 4
...lobe, hundreds of millions of acres of once-produc... a new report from researchers at Stanford Univers...his land was used to grow crops for conversion int...thout worsening the world food shortage or contrib...production for contributing to recent global food ...
...DC Engineered nanoscale materials (ENMs), which c...its for use in food packaging, raise new safety ev...ccording to a report released today by the Project...y Manufacturers Association (GMA). , The food-pa... share an interest in ensuring that any possible s...
...daylong event to help forge an agenda for maintain...tecting scientists from political meddling and cor...e NASA Goddard Institute for Space Studies, will s...ight Sides of Global Warming." Dr. Hansen is consi...nge and the need to take immediate action to curb ...
Other Biology News:Stanford study: Bioenergy potential of reviving abandoned agricultural land 2Stanford study: Bioenergy potential of reviving abandoned agricultural land 3Stanford study: Bioenergy potential of reviving abandoned agricultural land 4Use of nanomaterials in food packaging poses regulatory challenges 2NASA scientist James Hansen to speak at July 11 conference on 'Rejuvenating Public Sector Science' 2
...rade; SAPK/JNK (Thr183/Tyr185) Antibody Kit Kit I...dy, Catalog #9251, 200 ul SAPK/JNK (56G8) Rabbit m...Catalog #9253, (4 Western mini-blots) Anti-rabbit ...ti-biotin IgG, HRP-linked Antibody, Catalog #7075,...
Duck Anti-Phenytoin-BSA Antibody, Unconjugated from Good Biotech Corp
Rabbit Anti-GPCR TM7XN1 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-MEF2A, phospho (Thr312) Antibody, Unconjugated from Spring Bioscience
Biology Products: